Telik Announces Orphan Designation of Telintra® for Treatment of Myelodysplastic Syndrome

[at noodls] – TELIK ANNOUNCES ORPHAN DESIGNATION OF TELINTRA® FOR TREATMENT OF MYELODYSPLASTIC SYNDROME Palo Alto, CA – January 11, 2013 – Telik, Inc. (Nasdaq: TELK) was notified today that its product candidate, ezatiostat … more

View todays social media effects on TELK

View the latest stocks trending across Twitter. Click to view dashboard

See who Telik is hiring next, click here to view